BIOXYTRAN, INC
Datakwaliteit: 83%
BIXT
OTC
Manufacturing
Chemicals
€ 0,04
▼
€ 0,00
(-2,63%)
Marktkapitalisatie: 4,50 M
Prijs
€ 0,04
Marktkapitalisatie
4,50 M
Dagbereik
€ 0,04 — € 0,04
52-Weeksbereik
€ 0,03 — € 0,20
Volume
89.500
Openen € 0,04
50D / 200D Gem.
€ 0,04
15,53% below
50D / 200D Gem.
€ 0,07
46,06% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -247.174,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,00
Interest Coverage-9,44
Waardering
PE (TTM)
-2,13
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,1 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -2,11 M |
| ROE | N/A | ROA | -1391,19% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -247.174,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,00 |
| Interest Coverage | -9,44 | Asset Turnover | N/A |
| Working Capital | -3,05 M | Tangible Book Value | -3,05 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,13 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -5,49% | ||
| Market Cap | 4,50 M | Enterprise Value | 4,50 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,03 | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 11,70% |
| SBC-Adj. FCF | -255.590 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -2,37 M | -4,28 M | -2,46 M | -4,53 M | -2,54 M |
| EPS (Diluted) | -0,02 | -0,03 | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -2,22 M | -3,82 M | -2,13 M | -4,21 M | -1,27 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 112.337,0 | 1,15 M | 977.768,0 | 2,01 M | 544.519,0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 84.240,0 | — | 2,02 M | 236.577,0 | 1,01 M |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 138.694,0 | 137.638,0 | 370.936,0 | 119.290,0 | 326.403,0 |
| Total Liabilities | 1,93 M | 3,25 M | 3,66 M | 3,28 M | 2,27 M |
| Shareholders' Equity | -1,79 M | -3,11 M | -3,29 M | -3,16 M | -1,94 M |
| Total Debt | 48.000,0 | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — |
| Current Assets | 5.154,0 | 26.086,0 | 295.401,0 | 72.358,0 | 316.403,0 |
| Current Liabilities | 1,93 M | 3,25 M | 3,66 M | 3,28 M | 2,27 M |
{"event":"ticker_viewed","properties":{"ticker":"BIXT","listing_kind":"stock","pathname":"/stocks/bixt","exchange":"OTC","country":"US"}}